Updated hourlyHourly refreshSat, Sep 5, 2026
Press Release Database
Recent press releases, indexed by topic.
Healthcare
Sunday 30 August, 2026 Chartered Psychologist/Senior Accredited Psychotherapist Launches Foodsane: A Compassion-Led Alternative to Diet Culture Devon, UK. Dr Joanna North, Chartered Researching Psychologist, Fellow of the British Psychological Society, and Senior Accredited Psychotherapist, has launched Foodsane, a psychology-based wellness community offering a "middle way" between diet culture, weight loss medication and disordered eating. (www.foodsane.co.uk). Drawing on more than forty years of clinical practice, Dr North developed the RAFT framework: Right Amount, Right Food, Right Time and the accompanying concept of Time Related Eating (TRE), both grounded in nervous-system regulation, interoception (body awareness), and self-compassion rather than restriction or willpower. The initi
Aug 30 · 20:17·Pressat
Finance · Healthcare
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / August 30, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Fractyl Health, Inc. (NASDAQ:GUTS) securities. If you suffered a loss on your Fractyl Health, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Fractyl Health, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against ..
Aug 30 · 15:45·PR-Inside
Finance · Healthcare
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / August 30, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Fractyl Health, Inc. ("Fractyl" or the "Company") (NASDAQ:GUTS) and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 26-cv-07167, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Fractyl securities between January 13, 2025 and January 29, 2026, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations ..
Aug 30 · 15:02·PR-Inside
Healthcare
New immunizations guidelines for pregnant women help protect moms and babies from common preventable diseases The post Intermountain Health Experts Explain ACOG Guidelines for Immunizations for Pregnant Women first appeared on
Aug 30 · 14:57·PRUnderground
Healthcare
Caleb Colona completes the Dig Deep Foundations Series with works spanning fiction, parable, health, finance, and identity all organized around the RESET, BUILD, RISE framework. [PR.com]
Aug 30 · 12:55·PR.com
Finance · Healthcare
CAMBRIDGE, Mass., August 30, 2026--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new data at the European Society of Cardiology (ESC) Congress 2026 demonstrating the strength of RNAi-powered silencing for cardiovascular disease. The findings further reinforce the clinical profile of AMVUTTRA® (vutrisiran) across transthyretin amyloidosis (ATTR) patient populations, treatment settings, and manifestations of disease.
Aug 30 · 12:23·mlpr-businesswire
Healthcare · Retail
Aeitto, a user-centric kitchen appliance brand serving health-focused households across North America, today unveiled its new Max6 Slow Juicer, centered on a revolutionary filter-free design that solves the biggest consumer headache: tedious, brush-dependent cleanup after juicing. [PR.com]
Aug 30 · 12:08·PR.com
Healthcare
WHIPPANY, N.J., August 30, 2026--Bayer today announced the presentation of first detailed results from the Phase III REVEAL study, an investigator-initiated study by Brigham and Women’s Hospital, that evaluated the investigational positron emission tomography (PET) radiotracer iodine 124 evuzamitide (I 124 evuzamitide) for the diagnosis of cardiac amyloidosis.1 The pivotal study met its primary endpoints in the assessment of sensitivity and specificity for the diagnosis of cardiac amyloidosis ba
Aug 30 · 11:45·mlpr-businesswire
Healthcare
- Expected to enroll approximately 4,600 participants with obesity or overweight across two pivotal trials (AURORA-1 and AURORA-2) in the U.S., Europe, and Canada. - Global Phase III clinical program to investigate efficacy and safety of three maintenance doses (20 mg, 40 mg, and 60 mg)...
Aug 30 · 10:15·PR Newswire
Healthcare
ZIBO, Chine, 30 août 2026 /PRNewswire/ -- INTCO Medical (la « société », 300677.SZ), l'un des principaux fabricants mondiaux de gants jetables, annonce un chiffre d'affaires de 6,91 milliards RMB (environ 1,03 milliard USD) pour le semestre clos le 30 juin 2026, soit une hausse de 40,61%...
Aug 30 · 04:06·PR Newswire
Healthcare
ZIBO, China, 30. August 2026 /PRNewswire/ -- INTCO Medical („das Unternehmen", 300677.SZ), ein weltweit führender Hersteller von Einweghandschuhen, meldete für die sechs Monate bis zum 30. Juni 2026 einen Umsatz von 6,91 Mrd. RMB (ca. 1,03 Mrd. US-Dollar), ein Plus von 40,61 % gegenüber...
Aug 30 · 03:36·PR Newswire
Healthcare
ZIBO, China, 30 augustus 2026 /PRNewswire/ -- INTCO Medical ("het bedrijf", 300677.SZ), een toonaangevende wereldwijde fabrikant van wegwerphandschoenen, rapporteerde een omzet van RMB 6,91 miljard (ongeveer USD 1,03 miljard) voor het semester dat eindigt op 30 juni 2026, een stijging van...
Aug 30 · 02:40·PR Newswire